Ficha del valor · trimestre archivado
CPRX
Catalyst Pharmaceuticals, Inc. · Healthcare · Biotechnology
17Tenedores rastreados
+1Δ titulares
43.29MAcciones mantenidas
$939.35MValor declarado
+1Nuevas posiciones
−0Cierres
Señales de momentum (gestores comparables):
amplitud de titulares +6.2% ·
flujo de acciones +0.3% ·
nuevas posiciones netas +5.9%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 109 | -4 | 77.02M | $2.42B | +12 | −16 |
| Q1 2026 | 116 | +4 | 78.68M | $1.95B | +8 | −4 |
| Q4 2025 | 111 | 0 | 78.17M | $1.82B | — | — |
| Q3 2025 | 19 | 0 | 48.11M | $947.78M | — | −1 |
| Q2 2025 | 17 | +1 | 43.29M | $939.35M | +1 | — |
| Q1 2025 | 13 | -1 | 14.99M | $363.56M | — | −1 |
| Q4 2024 | 14 | 0 | 15.06M | $314.25M | +1 | −1 |
| Q3 2024 | 13 | +3 | 9.07M | $180.23M | +4 | −1 |
| Q2 2024 | 10 | — | 9.29M | $143.84M | — | — |
Quién lo tiene en cartera · Q2 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasivo) | 18.90M | — | $410.14M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (pasivo) | 8.77M | — | $190.22M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (pasivo) | 8.77M | — | $190.22M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (pasivo) | 8.77M | — | $190.22M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (pasivo) | 8.77M | — | $190.22M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (pasivo) | 8.77M | — | $190.22M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | State Street Global Advisors ✦ (pasivo) | 5.48M | -0.9% | $118.88M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 3.25M | +10.0% | $70.56M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 23 | Geode Capital Management ✦ (pasivo) | 2.87M | +3.7% | $62.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Geode Capital Management ✦ (pasivo) | 2.87M | +3.7% | $62.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Arrowstreet Capital ✦ | 1.22M | +18.2% | $26.55M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 26 | T. Rowe Price ✦ | 735.70K | -24.8% | $15.97M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 735.70K | -24.8% | $15.97M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 509.11K | — | $11.05M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Fidelity (FMR) ✦ | 509.11K | — | $11.05M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Millennium Management ✦ | 430.13K | +41.7% | $9.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 398.42K | -10.6% | $8.65M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 398.42K | -10.6% | $8.65M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 398.42K | -10.6% | $8.65M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 398.42K | -10.6% | $8.65M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 398.42K | -10.6% | $8.65M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | Citadel Advisors ✦ | 259.99K | -62.1% | $5.64M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Marshall Wace ✦ | 140.82K | Nuevo | $3.06M | 0.0% | New | 1 | SEC ↗ |
| 38 | Marshall Wace ✦ | 140.82K | Nuevo | $3.06M | 0.0% | New | 1 | SEC ↗ |
| 39 | Gotham Asset Management ✦ | 109.72K | +131.9% | $2.38M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | Fisher Asset Management ✦ | 83.14K | +1.2% | $1.80M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 41 | D. E. Shaw & Co. ✦ | 73.97K | -26.3% | $1.61M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 42 | D. E. Shaw & Co. ✦ | 73.97K | -26.3% | $1.61M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 43 | Wellington Management ✦ | 46.36K | -4.3% | $1.01M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 44 | Wellington Management ✦ | 46.36K | -4.3% | $1.01M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 45 | Wellington Management ✦ | 46.36K | -4.3% | $1.01M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 46 | Wellington Management ✦ | 46.36K | -4.3% | $1.01M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 47 | Norges Bank ✦ (pasivo) | 13.77K | 0.0% | $298,722 | 0.0% | Held | 4 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $3.06M | 0.0% |
| Marshall Wace | $3.06M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 378 tenedores, 103.75M acciones, $2.50B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q2 2025 ·
Metodología ·
Obtener esto a través de la API